Latest Close
₹679.20
+2.47%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹777.48
200 DMA
₹708.40
1 year gain / loss
−₹18.40(-2.64%)
₹697.60 → ₹679.20· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-11-01 · Financial period Jun 2026 · Consolidated figures where available
Aster DM Healthcare Limited is an India-based healthcare service provider. The Company is operating in India with a presence across primary, secondary, tertiary, and quaternary healthcare through approximately 19 hospitals with 5,159 beds, 10 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 262 labs and patient experience centers across five states in India. Its center of excellence includes oncology (AIIO), cardiac sciences, neurosciences, gastro sciences, integrated liver care, multi-organ transplant, orthopedics, obstetrics and gynecology, and pediatrics and neonatology. Its pharmacy offers various product categories, including prescription, OTC drugs, personal care and hygiene, feminine care, baby care, wellness, sports nutrition, surgical and disposables, and medical devices. Its labs deliver diagnostic services covering biochemistry, microbiology, hematology, clinical pathology, histopathology and cytogenetics.
Market Cap
₹59,570.09 Cr
P/E
164.28×
Sector 78.49× · above
P/B
14.16×
Sector 3.46× · above
EV / EBITDA
66.59×
Sector 19.96× · above
ROE
8.48%
Sector -30.49%
ROCE
10.10%
Sector 10.87%
ROA
4.47%
Sector 3.92%
Cash Flow / Profit
1.54×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Jun 2026 | 1,347.71 +10.6% | 78.08 | 29.28 -80.9% |
| Mar 2026 | 1,218.58 +0.4% | 163.35 | 153.58 +161.9% |
| Dec 2025 | 1,213.73 -1.0% | 103.05 | 58.65 -51.6% |
| Sep 2025 | 1,225.46 | 166.85 | 121.31 |
Dividend
02 Apr 2026 · ₹3